Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Mary E. Teresi"'
Autor:
Zoe E. Kienenberger, Tyler O. Farber, Mary E. Teresi, Francesca Milavetz, Sachinkumar B. Singh, Katie Larson Ode, Theodosia Thoma, Rebecca L. Weiner, Kathryn R. Burlage, Anthony J. Fischer
Publikováno v:
Canadian Respiratory Journal, Vol 2023 (2023)
Introduction. Cystic Fibrosis Foundation guidelines recommend people with CF perform daily airway clearance. This can be difficult for patients, as some find it time consuming or uncomfortable. Data comparing airway clearance methods are limited. We
Externí odkaz:
https://doaj.org/article/865bb73d63ae43d49f2cd992ddd536d9
Autor:
Stephanie L Rolsma, Guohua An, Nick Fishbane, William Fissell, Kenan Gu, Natalia Jimenez, Carl Kirkpatrick, Cornelia B Landersdorfer, Roger L Nation, Pratish C Patel, Andrew G Sokolow, Katherine Sokolow, Mary E Teresi, Marissa Kontos, Amy Watanabe, Patricia Winokur, C Buddy Creech
Publikováno v:
Open Forum Infectious Diseases. 9
Background Patients with cystic fibrosis (CF) experience recurrent bacterial pulmonary exacerbations. The management of these infections becomes increasingly complex due to decreased antimicrobial susceptibility and inadequate pharmacokinetic/pharmac
Autor:
Anthony Fischer, Zoe Kienenberger, Tyler O. Farber, Mary E. Teresi, Francesca Milavetz, Sachinkumar Singh, Katie Larson-Ode, Theodosia Thoma, Rebecca Weiner, Kathryn R. Burlage
Introduction: Cystic Fibrosis Foundation guidelines recommend people with CF perform daily airway clearance. This can be difficult for patients to complete, as some find it time consuming or uncomfortable. Data comparing airway clearance methods are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::927a6b8958090830fc5f9635f5ea5d1d
https://doi.org/10.22541/au.166170965.56638443/v1
https://doi.org/10.22541/au.166170965.56638443/v1
Autor:
Timothy D. Starner, Joseph E. Cavanaugh, Douglas B. Hornick, Lakshmi Durairaj, Janel Fedler, Janice L. Launspach, Sachinkumar B. Singh, Rebecca A. Horan, Mary E. Teresi, Thomas R. Santacroce, Joseph Zabner, George A. Nelson
Publikováno v:
J Cyst Fibros
Background Cystic fibrosis (CF) lung disease is characterized by chronic bacterial infection and recurrent pulmonary exacerbations. Xylitol is a 5-carbon sugar that can lower the airway surface salt concentration and augment innate immunity. We exami
Publikováno v:
Journal of the American Pharmacists Association. 43:551-554
ority. At Eckerd, our pharmacy software vendor programmed the pharmacy system to track and manage such requests. It is very important for the pharmacy staff to distinguish between regular contact information and confidential communication requests an
Publikováno v:
Journal of the American Pharmaceutical Association (1996). 42:374-378
Autor:
Mary E. Teresi, Mark R. Weatherly, Kathleen A. Hilliard, Janice L. Launspach, Richard C. Ahrens, Moira L. Aitken, Nael A. McCarty, Warren E. Regelmann, Michael W. Konstan, Thomas A. Standaert, Cynthia Tuthill, Thomas J. Kelley, Laura J H Milgram
Publikováno v:
Pediatric Pulmonology. 33:90-98
CPX (8-cyclopentyl-1,3-dipropylxanthine) is a novel compound currently under development as a potential treatment for cystic fibrosis (CF). The drug has been shown to increase chloride efflux and CFTR trafficking in vitro in CF airway cells. This pha
Autor:
Kathleen A. Hilliard, Moira L. Aitken, Michael W. Konstan, Mary E. Teresi, Mark R. Weatherly, Richard C. Ahrens, Thomas A. Standaert, Laura J H Milgram, Thomas J. Kelley, Nael A. McCarty, Janice L. Launspach, Seung-Ho Han
Publikováno v:
Pediatric Pulmonology. 33:142-150
One of the goals of current research in cystic fibrosis (CF) is to develop treatments that correct or compensate for defects in function of the cystic fibrosis transmembrane regulator (CFTR) gene. The use of outcome measures that assess CFTR function
Publikováno v:
Pharmacotherapy. 21:534-539
Study Objective. To compare the in vitro performance of an ultrasonic nebulizer and a jet nebulizer in producing a respirable aerosol of tobramycin solution for injection. Design. In vitro observational study. Devices. Ultrasonic and jet nebulizers.
Autor:
John P. O'Donnell, Patrick K. Noonan, Paul M. Webster, Mary E. Teresi, Charles E. Riggs, Michael J. Adams
Publikováno v:
Annals of Pharmacotherapy. 27:1434-1438
OBJECTIVE: To compare the bioequivalence of a generic methotrexate (MTX) tablet (Mylan) with that of a brand-name (Lederle) product. DESIGN: A single-dose, randomized, crossover study. SETTING: Clinical Research Center (CRC) at a university hospital.